Danaher price target raised to $265 from $255 at Jefferies

Jefferies raised the firm’s price target on Danaher (DHR) to $265 from $255 and keeps a Buy rating on the shares. The Q4 update was uneventful given prior commentary, and messaging was generally upbeat, with order trends supportive of high-single digit growth in 2026, the analyst tells investors in a research note. The firm said the post-call debate hinges on areas of upside, including bioprocessing equipment and life sciences, with the pathway and cadence key to shares moving higher. The firm added that a more constructive M&A backdrop also adds a potential catalyst.